Glaukos Submits NDA for Non-Invasive Keratoconus Treatment
The candidate for FDA approval is an epi-on evolution of their previous iLink procedure. Glaukos Corporation (California, USA) has announced…
The candidate for FDA approval is an epi-on evolution of their previous iLink procedure. Glaukos Corporation (California, USA) has announced…
![[TFG] ESCRS Refractive Surgery Series ep. 1 thumbnail TFG Refractive Surgery Series Understanding Patient Perspectives (1) (1)](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2024/12/TFG-ESCRS-Refractive-Surgery-Series-ep.-1-thumbnail-TFG-Refractive-Surgery-Series-Understanding-Patient-Perspectives-1-1-579x326.png)
![[TFG] ESCRS Refractive Surgery Series ep. 1 thumbnail TFG Refractive Surgery Video Inte](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/02/TFG-ESCRS-Refractive-Surgery-Series-ep.-1-thumbnail-TFG-Refractive-Surgery-Video-Inte-579x326.png)
![[Internal] Data Visualization Video Dr. Gus Gazzard thumbnail Science Saves Sight Prof. Gus Gazzard on SLT vs. Drops for Glaucoma and IOP Control](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/01/Internal-Data-Visualization-Video-Dr.-Gus-Gazzard-thumbnail-Science-Saves-Sight-Prof.-Gus-Gazzard-on-SLT-vs.-Drops-for-Glaucoma-and-IOP-Control-579x326.jpg)
